Apellis Pharmaceuticals to Host Conference Call on August 9, 2021 to Discuss Second Quarter 2021 Financial Results

NEXT STORY
AREV Signs Definitive Collaborative Development Agreement with Voynich Biosciences and Invites Richard van Breemen PhD to SAB
PREV STORY
Teleflex Announces Quarterly Dividend
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Bavarian Nordic Announces First Half 2018 Results

COPENHAGEN, Denmark, August 16, 2018 - Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announced ...

author_avatar
NASDAQ Market News

Horizon Pharma plc Announces the U.S. Patent and Trademark Office Issuance of an Additional Notice of Allowance With Claims Covering RAYOS® (prednisone) Delayed-Release Tablets

DUBLIN, Ireland, Aug. 18, 2016 (GLOBE NEWSWIRE) -- Horizon Pharma plc (NASDAQ:HZNP), a biopharmaceutical ...

author_avatar
NASDAQ Market News

GreeneStone Adds Two New Directors to the Board

TORONTO, Nov. 05, 2015 (GLOBE NEWSWIRE) -- GreeneStone Healthcare Corporation (OTCQB:GRST) (“GreeneStone” “GRST” or ...

author_avatar
NASDAQ Market News